These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity. Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499 [TBL] [Abstract][Full Text] [Related]
11. Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice. Kim EH; Park HJ; Han GY; Song MK; Pereboev A; Hong JS; Chang J; Byun YH; Seong BL; Nguyen HH J Virol; 2014 Sep; 88(17):9693-703. PubMed ID: 24920793 [TBL] [Abstract][Full Text] [Related]
12. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine. Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378 [TBL] [Abstract][Full Text] [Related]
13. Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus. Xu K; Ling ZY; Sun L; Xu Y; Bian C; He Y; Lu W; Chen Z; Sun B Viral Immunol; 2011 Feb; 24(1):45-56. PubMed ID: 21319978 [TBL] [Abstract][Full Text] [Related]
14. Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine. Ashraf S; Kong W; Wang S; Yang J; Curtiss R Vaccine; 2011 May; 29(23):3990-4002. PubMed ID: 21466806 [TBL] [Abstract][Full Text] [Related]
15. Subcutaneous immunization with recombinant adenovirus expressing influenza A nucleoprotein protects mice against lethal viral challenge. Hashem A; Jaentschke B; Gravel C; Tocchi M; Doyle T; Rosu-Myles M; He R; Li X Hum Vaccin Immunother; 2012 Apr; 8(4):425-30. PubMed ID: 22370512 [TBL] [Abstract][Full Text] [Related]
16. Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice. Huang B; Wang W; Li R; Wang X; Jiang T; Qi X; Gao Y; Tan W; Ruan L Virol J; 2012 Dec; 9():322. PubMed ID: 23272943 [TBL] [Abstract][Full Text] [Related]
17. Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus Hemagglutinin. Brazzoli M; Magini D; Bonci A; Buccato S; Giovani C; Kratzer R; Zurli V; Mangiavacchi S; Casini D; Brito LM; De Gregorio E; Mason PW; Ulmer JB; Geall AJ; Bertholet S J Virol; 2016 Jan; 90(1):332-44. PubMed ID: 26468547 [TBL] [Abstract][Full Text] [Related]
18. Cross-protective efficacy of bivalent recombinant baculoviral vaccine against heterologous influenza H5N1 challenge. Prabakaran M; Kolpe AB; He F; Kwang J Vaccine; 2013 Feb; 31(10):1385-92. PubMed ID: 23328313 [TBL] [Abstract][Full Text] [Related]
19. Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice. Mooney AJ; Li Z; Gabbard JD; He B; Tompkins SM J Virol; 2013 Jan; 87(1):363-71. PubMed ID: 23077318 [TBL] [Abstract][Full Text] [Related]
20. Broad protection against avian influenza virus by using a modified vaccinia Ankara virus expressing a mosaic hemagglutinin gene. Kamlangdee A; Kingstad-Bakke B; Anderson TK; Goldberg TL; Osorio JE J Virol; 2014 Nov; 88(22):13300-9. PubMed ID: 25210173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]